In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hexal, Nimodipin Drug Master File in Korea (Hexal, Nimodipin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hexal, Nimodipin. The MFDS reviews the Hexal, Nimodipin KDMF as part of the drug registration process and uses the information provided in the Hexal, Nimodipin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hexal, Nimodipin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hexal, Nimodipin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hexal, Nimodipin suppliers with KDMF on PharmaCompass.